The combined utility of three markers (CA19-9, MUC17 and MUC5AC in order of preference) was identified for differential diagnosis of precancerous polyps (polyps with malignant potential-SSA/P and TA) from benign polyps (HP) (Figure 3C). Here, MUC17 is linked to hyperplastic polyp.